Search

Search Constraints

You searched for: Author/Creator Sahm, Felix

Search Results

71. LGG-14. LOGGIC (Low Grade Glioma in Children) Core BioClinical Data Bank: Establishment and added clinical value of an international molecular diagnostic registry for pediatric low-grade glioma patients. (3rd June 2022)

72. LGG-18. Inhibition of Bcl-xL targets the senescent compartment of pilocytic astrocytoma. (3rd June 2022)

73. LGG-20. MOLECULARLY-DEFINED DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT) COMPRISES TWO SUBGROUPS WITH DISTINCT CLINICAL AND GENETIC FEATURES. Issue 2 (22nd June 2018)

74. LGG-33. ISOMORPHIC DIFFUSE GLIOMA HAS RECURRENT GENE FUSIONS OF MYBL1 OR MYB AND CAN BE DISTINGUISHED FROM OTHER MYB/MYBL1 ALTERED GLIOMAS BASED ON A DISTINCT MORPHOLOGY AND DNA METHYLATION PROFILE. (4th December 2020)

75. Loss of Mpdz impairs ependymal cell integrity leading to perinatal‐onset hydrocephalus in mice. Issue 7 (12th May 2017)

76. MBCL-06. RISK STRATIFICATION IMPROVEMENT OF THE HIT2000 AND I-HIT-MED COHORTS USING MOLECULAR SUBTYPES I-VIII OF GROUP 3/4 MEDULLOBLASTOMAS. (4th December 2020)

77. MBCL-07. NON-METASTATIC MEDULLOBLASTOMA OF EARLY CHILDHOOD: RESULTS FROM THE PROSPECTIVE CLINICAL TRIAL HIT-2000 AND AN EXTENDED VALIDATION COHORT. (4th December 2020)

78. MBCL-09. ISOLATED M1 METASTASES IN PEDIATRIC MEDULLOBLASTOMA: IS POSTOPERATIVE RADIOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY SUPERIOR TO POSTOPERATIVE SANDWICH-CHEMOTHERAPY AND RADIOTHERAPY?. (4th December 2020)

79. MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome. (3rd June 2022)

80. MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma. (3rd June 2022)